INTRODUCTION: Genetic effects contribute to individual differences in smoking behavior. Persistence to smoke despite known harmful health effects is mostly driven by nicotine addiction. As the physiological effects of nicotine are mediated by nicotinic acetylcholine receptors (nAChRs), we aimed at examining whether single nucleotide polymorphisms (SNPs) residing in nAChR subunit (CHRN) genes, other than CHRNA3/CHRNA5/CHRNB4 gene cluster previously showing association in our sample, are associated with smoking quantity or serum cotinine levels. METHODS: The study sample consisted of 485 Finnish adult daily smokers (age 30-75 years, 59% men) assessed for the number of cigarettes smoked per day (CPD) and serum cotinine level. We first studied SNPs residing on selected nAChR subunit genes (CHRNA2, CHRNA4, CHRNA6/CHRNB3, CHRNA7, CHRNA9, CHRNA10, CHRNB2, CHRNG/CHRND) genotyped within a genome-wide association study for single SNP and multiple SNP associations by ordinal regression. Next, we explored individual haplotype associations using sliding window technique. RESULTS: At one of the 8 loci studied, CHRNG/CHRND (chr2), single SNP (rs1190452), multiple SNP, and 2-SNP haplotype analyses (SNPs rs4973539-rs1190452) all showed statistically significant association with cotinine level. The median cotinine levels varied between the 2-SNP haplotypes from 220 ng/ml (AA haplotype) to 249 ng/ml (AG haplotype). We did not observe significant associations with CPD. CONCLUSIONS: These results provide further evidence that the γ-δ nAChR subunit gene region is associated with cotinine levels but not with the number of CPD, illustrating the usefulness of biomarkers in genetic analyses.
INTRODUCTION: Genetic effects contribute to individual differences in smoking behavior. Persistence to smoke despite known harmful health effects is mostly driven by nicotine addiction. As the physiological effects of nicotine are mediated by nicotinic acetylcholine receptors (nAChRs), we aimed at examining whether single nucleotide polymorphisms (SNPs) residing in nAChR subunit (CHRN) genes, other than CHRNA3/CHRNA5/CHRNB4 gene cluster previously showing association in our sample, are associated with smoking quantity or serum cotinine levels. METHODS: The study sample consisted of 485 Finnish adult daily smokers (age 30-75 years, 59% men) assessed for the number of cigarettes smoked per day (CPD) and serum cotinine level. We first studied SNPs residing on selected nAChR subunit genes (CHRNA2, CHRNA4, CHRNA6/CHRNB3, CHRNA7, CHRNA9, CHRNA10, CHRNB2, CHRNG/CHRND) genotyped within a genome-wide association study for single SNP and multiple SNP associations by ordinal regression. Next, we explored individual haplotype associations using sliding window technique. RESULTS: At one of the 8 loci studied, CHRNG/CHRND (chr2), single SNP (rs1190452), multiple SNP, and 2-SNP haplotype analyses (SNPs rs4973539-rs1190452) all showed statistically significant association with cotinine level. The median cotinine levels varied between the 2-SNP haplotypes from 220 ng/ml (AA haplotype) to 249 ng/ml (AG haplotype). We did not observe significant associations with CPD. CONCLUSIONS: These results provide further evidence that the γ-δ nAChR subunit gene region is associated with cotinine levels but not with the number of CPD, illustrating the usefulness of biomarkers in genetic analyses.
Authors: R E Straub; P F Sullivan; Y Ma; M V Myakishev; C Harris-Kerr; B Wormley; B Kadambi; H Sadek; M A Silverman; B T Webb; M C Neale; C M Bulik; P R Joyce; K S Kendler Journal: Mol Psychiatry Date: 1999-03 Impact factor: 15.992
Authors: Daniel J Schaid; Charles M Rowland; David E Tines; Robert M Jacobson; Gregory A Poland Journal: Am J Hum Genet Date: 2001-12-27 Impact factor: 11.025
Authors: Neal L Benowitz; Katherine M Dains; Delia Dempsey; Lisa Yu; Peyton Jacob Journal: Cancer Epidemiol Biomarkers Prev Date: 2010-05 Impact factor: 4.254
Authors: Marissa A Ehringer; Hilary V Clegg; Allan C Collins; Robin P Corley; Thomas Crowley; John K Hewitt; Christian J Hopfer; Kenneth Krauter; Jeffrey Lessem; Soo Hyun Rhee; Isabel Schlaepfer; Andrew Smolen; Michael C Stallings; Susan E Young; Joanna S Zeiger Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2007-07-05 Impact factor: 3.568
Authors: Ming D Li; Joke Beuten; Jennie Z Ma; Thomas J Payne; Xiang-Yang Lou; Veronica Garcia; Aristeo S Duenes; Karen M Crews; Robert C Elston Journal: Hum Mol Genet Date: 2005-03-24 Impact factor: 6.150
Authors: Helen M Kamens; Robin P Corley; Phillip A Richmond; Todd M Darlington; Robin Dowell; Christian J Hopfer; Michael C Stallings; John K Hewitt; Sandra A Brown; Marissa A Ehringer Journal: Behav Genet Date: 2016-04-16 Impact factor: 2.805
Authors: Shaolin Wang; Andrew D van der Vaart; Qing Xu; Chamindi Seneviratne; Ovide F Pomerleau; Cynthia S Pomerleau; Thomas J Payne; Jennie Z Ma; Ming D Li Journal: Hum Genet Date: 2013-11-20 Impact factor: 4.132
Authors: A Agrawal; K J H Verweij; N A Gillespie; A C Heath; C N Lessov-Schlaggar; N G Martin; E C Nelson; W S Slutske; J B Whitfield; M T Lynskey Journal: Transl Psychiatry Date: 2012-07-17 Impact factor: 6.222
Authors: Jennifer O'Loughlin; Marie-Pierre Sylvestre; Aurélie Labbe; Nancy C Low; Marie-Hélène Roy-Gagnon; Erika N Dugas; Igor Karp; James C Engert Journal: PLoS One Date: 2014-12-29 Impact factor: 3.240
Authors: Leah S Richmond-Rakerd; Jacqueline M Otto; Wendy S Slutske; Cindy L Ehlers; Kirk C Wilhelmsen; Ian R Gizer Journal: Nicotine Tob Res Date: 2017-04-01 Impact factor: 4.244
Authors: Andrew W Bergen; Ruth Krasnow; Harold S Javitz; Gary E Swan; Ming D Li; James W Baurley; Xiangning Chen; Lenn Murrelle; Barbara Zedler Journal: BMC Public Health Date: 2015-09-07 Impact factor: 3.295